intramuscular

R&D

COVID-19 is still circulating and there are fears that further spikes in cases are to be expected in the coming months.

News

Amgen's Imdelltra and AstraZeneca's Imfinzi have improved survival compared to Imfinzi alone as first-line maintenance treatment for ES-SCLC.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.